USPTO serial 79339358
SANYASE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 21, 2023
- Examiner
- CHHINA, KARANENDRA S
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with SANYASE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Douglas T. Johnson
Douglas T. Johnson Miller & Martin PLLC832 Georgia AvenueSuite 1200 Volunteer BuildingChattanooga, TN 37402-2289Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medical reagents for use in rapid clinical, pharmaceutical and diagnostic testing, namely, for use in measurement in a bodily fluid of in vitro coagulation, platelet function, and/or for use in determination in a bodily fluid of the presence of anti-coagulants and/or platelet inhibitors | ACTIVE | — |
| 009 | Computer hardware, namely, desktop computers and handheld computers, detection devices and/or adaptors for connecting to a photometer for luminescence; downloadable and recorded software to be used in the field of rapid clinical and diagnostic testing, namely, for measurement in a bodily fluid of in vitro coagulation, platelet function, and/or determination in a bodily fluid of the presence of anti-coagulants and/or platelet inhibitors | ACTIVE | — |
| 010 | Medical testing apparatus and instruments with their parts for clinical, pharmaceutical and diagnostic use, namely, use in laboratories and points of care for use in measurement in a bodily fluid of in vitro or in vivo coagulation, platelet function, and/or determination in a bodily fluid of the presence of anti-coagulants and/or platelet inhibitors and/or platelet metabolite markers; microplates, cuvettes and disposable cartridges for use in rapid clinical and diagnostic testing for medical purposes, namely, for use in measurement in a bodily fluid of in vitro coagulation, platelet function, and/or determination in a bodily fluid of the presence of anti-coagulants and/or platelet inhibitors | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by SANYGO B.V.
- Other trademarks owned by SANYGO B.V.
- Other trademarks owned by SANYGO B.V.
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named SANYASE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 18, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 22, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 22, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 21, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 21, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Nov 21, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 24, 2023 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Oct 4, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 4, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Sep 5, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 5, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 4, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 16, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 16, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 16, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 27, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 25, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 24, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 24, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 14, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 25, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 25, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 25, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 24, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 22, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 13, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 17, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 12, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 9, 2022 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Apr 28, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |